Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.

ABSTRACT:

SUBMITTER: Lai ZW 

PROVIDER: S-EPMC5891154 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature